• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

庆大霉素负载聚(L-丙交酯)微粒形成过程中工艺变量对残留溶剂去除及聚合物形态的影响

Process variable implications for residual solvent removal and polymer morphology in the formation of gentamycin-loaded poly (L-lactide) microparticles.

作者信息

Falk R F, Randolph T W

机构信息

Department of Chemical Engineering, University of Colorado, Boulder 80309, USA.

出版信息

Pharm Res. 1998 Aug;15(8):1233-7. doi: 10.1023/a:1011991808423.

DOI:10.1023/a:1011991808423
PMID:9706054
Abstract

PURPOSE

The purpose was to determine the influence of process parameters in the precipitation with a compressed antisolvent (PCA) process on the morphology and residual dichloromethane (DCM) levels in gentamycin-loaded PLA microparticles.

METHODS

The three variables studied were the rate of CO2 co-flowed during the polymer and drug post-precipitation, the post-precipitation pure CO2 flush rate, and the post-precipitation CO2 flush volume. Residual DCM levels were determined from headspace gas chromatography-mass spectroscopy (GC-MS) with single ion monitoring. X-ray diffraction (XRD) and differential scanning calorimetry (DSC) were used to estimate the crystallinity within microparticles. DCM was extracted from drug-loaded microparticles by both supercritical CO2 extraction and vacuum drying for up to two days to determine a lower limit for solvent removal.

RESULTS

Increasing either the post-precipitations CO2 flow rate or flush volume resulted in lower residual DCM levels in the microparticle. The CO2 co-flow rate showed an opposite trend. Increasing in value resulted in a higher DCM value after precipitation. XRD and DSC analysis on these samples suggest that those produced at lower CO2 co-flow rates have a higher degree of crystallinity, which increases the diffusivity of DCM through the polymer matrix. Finally, samples subjected to extended (48 hr) CO2 extraction resulted in DCM levels on the order of one to three ppm.

CONCLUSIONS

Specific PCA process conditions during microparticle formation have a strong influence on the residual solvent levels within the microparticles. Polymer morphology affects the diffusivity of solvent through the polymer matrix, which in turn determines the solvent removal rates.

摘要

目的

本研究旨在确定压缩抗溶剂(PCA)沉淀过程中的工艺参数对载有庆大霉素的聚乳酸(PLA)微粒形态和残余二氯甲烷(DCM)水平的影响。

方法

研究的三个变量分别为聚合物和药物沉淀后二氧化碳的共流速率、沉淀后纯二氧化碳的吹扫速率以及沉淀后二氧化碳的吹扫体积。残余DCM水平通过顶空气相色谱 - 质谱联用仪(GC - MS)的单离子监测来测定。采用X射线衍射(XRD)和差示扫描量热法(DSC)估算微粒内部的结晶度。通过超临界二氧化碳萃取和真空干燥长达两天,从载药微粒中提取DCM,以确定溶剂去除的下限。

结果

增加沉淀后二氧化碳的流速或吹扫体积会使微粒中的残余DCM水平降低。二氧化碳共流速率呈现相反趋势,其值增加会导致沉淀后DCM值升高。对这些样品进行XRD和DSC分析表明,在较低二氧化碳共流速率下制备的样品具有更高的结晶度,这增加了DCM在聚合物基质中的扩散率。最后,经过延长(48小时)二氧化碳萃取的样品,其DCM水平在1至3 ppm量级。

结论

微粒形成过程中的特定PCA工艺条件对微粒内的残余溶剂水平有很大影响。聚合物形态会影响溶剂在聚合物基质中的扩散率,进而决定溶剂去除速率。

相似文献

1
Process variable implications for residual solvent removal and polymer morphology in the formation of gentamycin-loaded poly (L-lactide) microparticles.庆大霉素负载聚(L-丙交酯)微粒形成过程中工艺变量对残留溶剂去除及聚合物形态的影响
Pharm Res. 1998 Aug;15(8):1233-7. doi: 10.1023/a:1011991808423.
2
Production of drug loaded microparticles by the use of supercritical gases with the aerosol solvent extraction system (ASES) process.利用超临界气体和气溶胶溶剂萃取系统(ASES)工艺制备载药微粒。
J Microencapsul. 1996 Mar-Apr;13(2):131-9. doi: 10.3109/02652049609052902.
3
Polymeric microspheres prepared by spraying into compressed carbon dioxide.通过喷雾进入压缩二氧化碳制备的聚合物微球。
Pharm Res. 1995 Aug;12(8):1211-7. doi: 10.1023/a:1016276329672.
4
Preparation of budesonide and budesonide-PLA microparticles using supercritical fluid precipitation technology.使用超临界流体沉淀技术制备布地奈德及布地奈德-聚乳酸微粒。
AAPS PharmSciTech. 2002;3(3):E18. doi: 10.1208/pt030318.
5
Preparation of biodegradable microparticles using solution-enhanced dispersion by supercritical fluids (SEDS).使用超临界流体溶液增强分散法(SEDS)制备可生物降解的微粒。
Pharm Res. 1999 May;16(5):676-81. doi: 10.1023/a:1018868423309.
6
Preparation of large porous deslorelin-PLGA microparticles with reduced residual solvent and cellular uptake using a supercritical carbon dioxide process.采用超临界二氧化碳工艺制备具有低残留溶剂和细胞摄取量的大孔去氨加压素-PLGA 微球。
Pharm Res. 2004 Mar;21(3):524-35. doi: 10.1023/B:PHAM.0000019308.25479.a4.
7
Formation of inhalable rifampicin-poly(L-lactide) microparticles by supercritical anti-solvent process.通过超临界抗溶剂法制备可吸入利福平-聚(L-丙交酯)微粒
AAPS PharmSciTech. 2008;9(4):1119-29. doi: 10.1208/s12249-008-9152-7. Epub 2008 Nov 7.
8
Supercritical antisolvent co-precipitation of rifampicin and ethyl cellulose.利福平与乙基纤维素的超临界抗溶剂共沉淀法
Eur J Pharm Sci. 2017 May 1;102:161-171. doi: 10.1016/j.ejps.2017.03.016. Epub 2017 Mar 14.
9
Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.使用超临界二氧化碳技术制备、表征负载吲哚美辛的聚乳酸/聚乳酸-羟基乙酸共聚物微粒及其体外细胞毒性
Eur J Pharm Biopharm. 2008 Sep;70(1):85-97. doi: 10.1016/j.ejpb.2008.03.011. Epub 2008 Mar 29.
10
Characterization and biological evaluation of paclitaxel-loaded poly(L-lactic acid) microparticles prepared by supercritical CO2.超临界二氧化碳制备的紫杉醇负载聚(L-乳酸)微粒的表征及生物学评价
Langmuir. 2008 Jul 15;24(14):7432-41. doi: 10.1021/la703900k. Epub 2008 Jun 12.

引用本文的文献

1
Preparation and Characterization of Fenofibrate Microparticles with Surface-Active Additives: Application of a Supercritical Fluid-Assisted Spray-Drying Process.含表面活性添加剂的非诺贝特微粒的制备与表征:超临界流体辅助喷雾干燥工艺的应用
Pharmaceutics. 2021 Dec 2;13(12):2061. doi: 10.3390/pharmaceutics13122061.
2
Sustained release ketamine-loaded porous silicon-PLGA microparticles prepared by an optimized supercritical CO process.优化的超临界 CO 2 工艺制备载持续释放氯胺酮多孔硅-PLGA 微球。
Drug Deliv Transl Res. 2022 Mar;12(3):676-694. doi: 10.1007/s13346-021-00991-w. Epub 2021 Apr 28.
3
Hydrophobic ion pairing: encapsulating small molecules, peptides, and proteins into nanocarriers.

本文引用的文献

1
Nebulization of NanoCrystals: production of a respirable solid-in-liquid-in-air colloidal dispersion.纳米晶体的雾化:制备可吸入的气-液-固胶体分散体。
Pharm Res. 1997 Jan;14(1):112-6. doi: 10.1023/a:1012024021511.
2
Residual solvents in biodegradable microparticles. Influence of process parameters on the residual solvent in microparticles produced by the aerosol solvent extraction system (ASES) process.
J Pharm Sci. 1997 Jan;86(1):101-5. doi: 10.1021/js960136o.
3
In vitro drug release behavior of D,L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method.采用新型自发乳化溶剂扩散法制备的载醋酸那法瑞林的聚(D,L-丙交酯/乙交酯)共聚物(PLGA)纳米球的体外药物释放行为
疏水离子对:将小分子、肽和蛋白质封装到纳米载体中。
Nanoscale Adv. 2019 Oct 1;1(11):4207-4237. doi: 10.1039/c9na00308h.
4
Formulation of Bioerodible Ketamine Microparticles as an Analgesic Adjuvant Treatment Produced by Supercritical Fluid Polymer Encapsulation.通过超临界流体聚合物包封制备可生物降解的氯胺酮微粒作为镇痛辅助治疗药物的制剂。
Pharmaceutics. 2018 Dec 6;10(4):264. doi: 10.3390/pharmaceutics10040264.
5
Preparation of polycaprolactone nanoparticles via supercritical carbon dioxide extraction of emulsions.通过超临界二氧化碳萃取乳液制备聚己内酯纳米粒子。
Drug Deliv Transl Res. 2018 Dec;8(6):1790-1796. doi: 10.1007/s13346-017-0422-3.
6
Increasing the dissolution rate of itraconazole processed by gas antisolvent techniques using polyethylene glycol as a carrier.提高以聚乙二醇为载体通过气体抗溶剂技术制备的伊曲康唑的溶解速率。
Pharm Res. 2008 Jun;25(6):1274-89. doi: 10.1007/s11095-007-9479-x.
7
Application of dense gas techniques for the production of fine particles.致密气体技术在细颗粒生产中的应用。
AAPS PharmSci. 2003;5(2):E11. doi: 10.1208/ps050211.
J Pharm Sci. 1994 May;83(5):727-32. doi: 10.1002/jps.2600830527.
4
In vitro and in vivo evaluation of thyrotrophin releasing hormone release from copoly(dl-lactic/glycolic acid) microspheres.聚(聚dl-乳酸/乙醇酸)微球释放促甲状腺激素释放激素的体外和体内评价
J Pharm Sci. 1994 May;83(5):636-40. doi: 10.1002/jps.2600830508.
5
Biodegradable controlled antibiotic release devices for osteomyelitis: optimization of release properties.用于骨髓炎的可生物降解的可控抗生素释放装置:释放特性的优化
J Pharm Pharmacol. 1994 Sep;46(9):718-24. doi: 10.1111/j.2042-7158.1994.tb03890.x.
6
In vitro release profiles of eristostatin from biodegradable polymeric microspheres: protein aggregation problem.抑肽素在可生物降解聚合物微球中的体外释放曲线:蛋白质聚集问题。
Biotechnol Prog. 1995 Mar-Apr;11(2):224-7. doi: 10.1021/bp00032a016.
7
Sub-micrometer-sized biodegradable particles of poly(L-lactic acid) via the gas antisolvent spray precipitation process.
Biotechnol Prog. 1993 Jul-Aug;9(4):429-35. doi: 10.1021/bp00022a010.
8
Polymeric microspheres prepared by spraying into compressed carbon dioxide.通过喷雾进入压缩二氧化碳制备的聚合物微球。
Pharm Res. 1995 Aug;12(8):1211-7. doi: 10.1023/a:1016276329672.
9
Comparison of new and existing spectrophotometric methods for the analysis of tobramycin and other aminoglycosides.用于分析妥布霉素和其他氨基糖苷类药物的新分光光度法与现有分光光度法的比较。
J Pharm Sci. 1990 May;79(5):428-31. doi: 10.1002/jps.2600790514.
10
Release of human serum albumin from poly(lactide-co-glycolide) microspheres.
Pharm Res. 1990 Nov;7(11):1190-4. doi: 10.1023/a:1015948829632.